| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 0 | 2 | 3 | 34 | 48 | 34 | 54 | 61 | 53 | 51 | 44 | 24 | 27 |
| Expenses | 5 | 14 | 11 | 41 | 58 | 52 | 71 | 94 | 68 | 59 | 58 | 29 | 28 |
| EBITDA | -5 | -11 | -8 | -7 | -10 | -18 | -17 | -33 | -15 | -8 | -14 | -5 | -0 |
| Operating Profit % | 0 % | -962 % | -246 % | -22 % | -21 % | -56 % | -33 % | -57 % | -30 % | -17 % | -35 % | -23 % | -16 % |
| Depreciation | 2 | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 7 | 6 | 6 |
| Interest | 4 | 1 | 4 | 5 | 6 | 6 | 6 | 5 | 3 | 5 | 6 | 7 | 7 |
| Profit Before Tax | -8 | -16 | -16 | -18 | -20 | -29 | -28 | -45 | -25 | -20 | -27 | -17 | -14 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -8 | -16 | -16 | -18 | -20 | -29 | -28 | -45 | -25 | -20 | -27 | -17 | -14 |
| EPS in ₹ | -8.24 | -12.49 | -11.68 | -12.97 | -12.83 | -17.90 | -14.37 | -20.81 | -11.30 | -9.15 | -12.49 | -7.85 | -6.50 |
Krebs Biochemicals & Industries
Krebs Biochemicals & Industries
56.86
+0.64
(1.14%)
Market Cap
122.59 Cr
PE Ratio
-8.58
Volume
5,820.00
Day High - Low
59.50 - 56.08
52W High-Low
81.80 - 38.33
There are new updates from the company1 day ago
View
Key Fundamentals
Market Cap
122.59 Cr
EPS
-7.85
PE Ratio
-8.58
PB Ratio
-0.74
Book Value
-75.49
EBITDA
-5.45
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
18.42
Debt to Equity
0.00
Actual
Company News
View All News
Citurgia Biochemicals received Registrar of Companies approval to extend its 51st AGM deadline. The new date is October 31, 2026, for FY26.
Citurgia Biochemicals reported a narrowed loss of ₹8.20 lakh in Q1FY27. The company recorded zero operating income for the quarter and the full year ended June 30, 2026.
Citurgia Biochemicals accepts CS resignation
Sep 08, 2026
Sep 08, 2026Citurgia Biochemicals Limited accepted the resignation of Yatendra Kumar as Company Secretary effective July 24, 2026. The firm cited an inadvertent oversight for the delayed submission of the resignation letter to BSE.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,846.40 | #1 4,43,013.21 | 36.99 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 41.29 | |
9,352.00 | 2,48,266.22 | 85.61 | 11,067.00 | 13.95 | 2,568 | 65.50 | 61.40 | |
4,935.00 | 1,87,711.54 | 87.65 | 13,886.20 | 20.34 | 2,138 | 3.28 | 51.09 | |
1,162.30 | 1,16,954.58 | 25.23 | 27,657.90 | 17.64 | 5,026 | -34.90 | 56.20 | |
1,384.10 | 1,11,813.87 | 33.34 | 29,044.60 | 2.24 | 3,870 | -39.18 | 45.24 | |
2,006.50 | 1,08,322.22 | 100.00 | 6,867.80 | 22.01 | 890 | #1 123.93 | 66.38 | |
2,480.00 | 1,02,423.00 | 48.54 | 14,636.40 | 14.85 | 1,938 | 29.13 | 62.86 | |
1,211.00 | 1,01,078.42 | 31.52 | 35,058.60 | 3.90 | 4,158 | -69.10 | 61.71 | |
1,700.00 | 97,814.24 | 26.63 | 34,145.20 | 5.56 | 3,503 | 25.21 | 56.69 | |
2,135.00 | 97,619.15 | #1 17.46 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 45.93 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-46.07 %
Net Income Growth
-37.06 %
Cash Flow Change
75.67 %
ROE
11.30 %
ROCE
148.03 %
EBITDA Margin (Avg.)
-34.95 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 108 | 116 | 122 | 126 | 142 | 134 | 159 | 190 | 175 | 178 | 169 | 163 |
| Fixed Assets | 58 | 93 | 102 | 101 | 101 | 105 | 118 | 139 | 147 | 150 | 146 | 143 |
| Current Assets | 15 | 9 | 13 | 17 | 31 | 19 | 21 | 36 | 16 | 17 | 10 | 10 |
| Capital Work in Progress | 0 | 11 | 4 | 4 | 4 | 4 | 12 | 8 | 4 | 2 | 3 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 50 | 13 | 16 | 21 | 38 | 24 | 29 | 43 | 24 | 26 | 20 | 0 |
| Total Equity & Liabilities | 108 | 116 | 122 | 126 | 142 | 134 | 159 | 190 | 175 | 178 | 169 | 163 |
| Current Liabilities | 29 | 30 | 32 | 42 | 55 | 43 | 48 | 78 | 49 | 62 | 104 | 113 |
| Non Current Liabilities | 61 | 74 | 89 | 101 | 102 | 116 | 154 | 187 | 225 | 236 | 212 | 213 |
| Total Equity | 18 | 13 | 2 | -18 | -14 | -25 | -43 | -75 | -100 | -119 | -146 | -163 |
| Reserve & Surplus | -14 | -4 | -12 | -32 | -31 | -43 | -67 | -97 | -121 | -141 | -168 | -184 |
| Share Capital | 10 | 13 | 14 | 14 | 17 | 18 | 20 | 22 | 22 | 22 | 22 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 6 | -6 | -0 | 0 | 17 | -17 | 1 | -1 | 0 | 0 | 0 | 0 |
| Investing Activities | -3 | -4 | -5 | -3 | -4 | -10 | -23 | -23 | -13 | -8 | -5 | -4 |
| Operating Activities | -45 | -15 | -11 | -6 | 4 | -36 | -15 | -17 | -25 | 2 | -8 | -2 |
| Financing Activities | 54 | 13 | 16 | 9 | 17 | 29 | 38 | 40 | 37 | 6 | 13 | 6 |
Share Holding
| % Holding | Mar 2021 | Apr 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 70.05 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % | 0.00 % | 0.50 % | 0.50 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.03 % | 17.32 % | 18.26 % | 19.34 % | 18.96 % | 19.24 % | 19.26 % | 18.77 % | 18.67 % | 18.57 % | 18.54 % | 18.80 % | 19.00 % | 20.11 % | 19.97 % | 19.80 % | 20.02 % | 20.42 % | 19.73 % | 19.70 % | 19.80 % | 19.81 % | 19.67 % |
| Others | 10.92 % | 9.94 % | 9.00 % | 7.91 % | 8.30 % | 8.01 % | 8.00 % | 8.48 % | 8.59 % | 8.68 % | 8.71 % | 8.45 % | 8.25 % | 6.65 % | 6.79 % | 6.96 % | 6.74 % | 6.34 % | 7.03 % | 7.06 % | 7.46 % | 6.95 % | 7.09 % |
| No of Share Holders | 0 | 6,400 | 6,400 | 7,096 | 8,571 | 8,166 | 9,531 | 9,533 | 9,650 | 9,294 | 9,393 | 9,030 | 8,990 | 8,909 | 8,848 | 9,425 | 9,091 | 8,798 | 9,118 | 8,912 | 8,710 | 8,553 | 8,521 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Sept 2026 |  Annual General Meeting | NA | 29 Sept 2026 | 52.12 | 56.22 |
| 01 Feb 2019 |  Rights | 21:100 | 31 Jan 2019 | 106.37 | 97.15 |
| 27 Sept 2024 | Annual General Meeting | NA | 27 Sept 2024 | 82.93 | 82.75 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 78.05 | 92.27 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 85.30 | 98.44 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 73.00 | 76.21 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 82.49 | 79.86 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 73.10 | 74.14 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 71.03 | 69.40 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 63.15 | 57.41 |
| 21 May 2026 | Quarterly Result Announcement | NA | 21 May 2026 | 61.85 | 54.99 |
| 06 Aug 2026 | Quarterly Result Announcement | NA | 06 Aug 2026 | 55.95 | 54.12 |
Announcements
Closure of Trading Window1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationSep 07, 2026
Sep 07, 2026Notice Of 34Th Annual General Meeting Of The CompanySep 04, 2026
Sep 04, 2026Reg. 34 (1) Annual Report.Sep 04, 2026
Sep 04, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2026
Sep 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2026
Aug 07, 2026ResultsAug 06, 2026
Aug 06, 2026Board Meeting Outcome for Outcome Of BMAug 06, 2026
Aug 06, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th Agust 2026Jul 28, 2026
Jul 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2026
Jul 02, 2026Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 26, 2026
Jun 26, 2026Board Meeting Outcome for Outcome Of Board MeetingJun 26, 2026
Jun 26, 2026Closure of Trading WindowJun 22, 2026
Jun 22, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2026
May 22, 2026Result For FY Ended 31.03.2026May 21, 2026
May 21, 2026Board Meeting Outcome for Outcome Of Board MeetingMay 21, 2026
May 21, 2026Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 07, 2026
May 07, 2026Clarification On Price MovementApr 10, 2026
Apr 10, 2026Clarification Sought from Krebs Biochemicals & Industries LtdApr 08, 2026
Apr 08, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2026
Feb 10, 2026Results Quarter Ended 31.12.2025Feb 09, 2026
Feb 09, 2026Board Meeting Outcome for Outcome Of Board MeetingFeb 09, 2026
Feb 09, 2026Board Meeting Intimation for Board Meeting Intimation To Consider And Adopt The Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended December 31 2025Jan 14, 2026
Jan 14, 2026Report On Re-Lodgement Of Transfer Requests Of Physical Shares Dec 2025Jan 05, 2026
Jan 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 02, 2026
Jan 02, 2026Closure of Trading WindowDec 22, 2025
Dec 22, 2025Report On Re-Lodgement Of Transfer Requests Of Physical Shares Nov 2025Dec 03, 2025
Dec 03, 2025Report On Re-Lodgement Of Transfer Requests Of Physical Shares Oct 2025Nov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2025
Nov 05, 2025Result Sept 2025Nov 04, 2025
Nov 04, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 04, 2025
Nov 04, 2025Board Meeting Intimation for Board Meeting Intimation For The Quarter Ended 30.09.2025.Oct 16, 2025
Oct 16, 2025Report On Re-Lodgement Of Transfer Requests Of Physical SharesOct 08, 2025
Oct 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 23, 2025
Sep 23, 2025Report On Re-Lodgement Of Transfer Requests Of Physical SharesSep 11, 2025
Sep 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Notice Of 33Rd Annual General Meeting Of The CompanyAug 28, 2025
Aug 28, 2025Reg. 34 (1) Annual Report.Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Board Comments On Fine Levied By ExchangesAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Aug 07, 2025ResultAug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Jul 25, 2025Technical Indicators
RSI(14)
Neutral 49.72
ATR(14)
Less Volatile 3.78
STOCH(9,6)
Neutral 20.32
STOCH RSI(14)
Oversold 13.39
MACD(12,26)
Bearish -0.06
ADX(14)
Strong Trend 27.34
UO(9)
Bullish 27.34
ROC(12)
Uptrend And Accelerating 2.39
WillR(14)
Oversold -80.25
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
